Literature DB >> 2880201

Does Down syndrome support homocysteine theory of arteriosclerosis?

L Brattström, E Englund, A Brun.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2880201     DOI： 10.1016/s0140-6736(87)91772-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  9 in total

1.  Trisomy-21 gene dosage over-expression of miRNAs results in the haploinsufficiency of specific target proteins.

Authors:  Terry S Elton; Sarah E Sansom; Mickey M Martin
Journal:  RNA Biol       Date:  2010-09-01       Impact factor: 4.652

Review 2.  Cerebrovascular contributions to aging and Alzheimer's disease in Down syndrome.

Authors:  Donna M Wilcock; Frederick A Schmitt; Elizabeth Head
Journal:  Biochim Biophys Acta       Date:  2015-11-26

3.  Homocysteine, factor VII and antithrombin III in subjects with different gene dosage for cystathionine beta-synthase.

Authors:  L Brattström; B Israelsson; L Tengborn; B Hultberg
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

Review 4.  Aging in Down Syndrome and the Development of Alzheimer's Disease Neuropathology.

Authors:  Elizabeth Head; Ira T Lott; Donna M Wilcock; Cynthia A Lemere
Journal:  Curr Alzheimer Res       Date:  2016       Impact factor: 3.498

5.  Cardiovascular Disease, Single Nucleotide Polymorphisms; and the Renin Angiotensin System: Is There a MicroRNA Connection?

Authors:  Terry S Elton; Sarah E Sansom; Mickey M Martin
Journal:  Int J Hypertens       Date:  2010-08-04       Impact factor: 2.420

6.  Lipid profiles of children with Down syndrome compared with their siblings.

Authors:  Tahira Adelekan; Sheela Magge; Justine Shults; Virginia Stallings; Nicolas Stettler
Journal:  Pediatrics       Date:  2012-05-14       Impact factor: 7.124

7.  Sterol lipid metabolism in down syndrome revisited: down syndrome is associated with a selective reduction in serum brassicasterol levels.

Authors:  Gavin Tansley; Daniel T Holmes; Dieter Lütjohann; Elizabeth Head; Cheryl L Wellington
Journal:  Curr Gerontol Geriatr Res       Date:  2012-05-09

8.  Risk of Major Cardiovascular Events in People with Down Syndrome.

Authors:  Christopher G Sobey; Courtney P Judkins; Vijaya Sundararajan; Thanh G Phan; Grant R Drummond; Velandai K Srikanth
Journal:  PLoS One       Date:  2015-09-30       Impact factor: 3.240

9.  Cerebrovascular pathology in Down syndrome and Alzheimer disease.

Authors:  Elizabeth Head; Michael J Phelan; Eric Doran; Ronald C Kim; Wayne W Poon; Frederick A Schmitt; Ira T Lott
Journal:  Acta Neuropathol Commun       Date:  2017-12-01       Impact factor: 7.801
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.